Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record displays details of the completed Phase 3 rheumatoid arthritis trial comparing upadacitinib with methotrexate, including its design, eligibility criteria, locations, and outcome measures. It also provides study publications, record dates, and information on sharing participant data and study documents.
    Difference
    100%
    Check dated 2026-11-07T12:23:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T13:08:02.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T16:26:01.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:10:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:15:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the study details are currently unavailable due to permission or server issues.
    Difference
    19%
    Check dated 2026-09-19T20:50:42.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.